(11) | Number of the document | 4363 |
(21) | Number of the application | a 2012 0125 |
(22) | Filing date of the application | 2011.05.19 |
| Date of filing the request for examination | (de fond) 02.06.2015 |
(71) | Name(s) of applicant(s), code of the country | E.I. DU PONT DE NEMOURS AND COMPANY, US; |
(72) | Name(s) of inventor(s), code of the country | CURRIE Martin James, US; |
(73) | Name(s) of owner(s), code of the country | E.I. DU PONT DE NEMOURS AND COMPANY, US; |
(54) | Title of the invention | Crystalline form of 4-[5-[3-chloro-5-(trifluoromethyl)phenyl]-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-N-[2-oxo-2-[(2,2,2-trifluoroethyl)amino]ethyl]-1-naphthalenecarboxamide and uses thereof |
(13) | Kind-of-document code | |
(51) | International Patent Classification | C07D 261/04 (2006.01); A01N 43/80 (2006.01); A01P 5/00 (2006.01); A01P 7/00 (2006.01); A61K 31/42 (2006.01); A61P 33/00 (2006.01); |
(19) | Country | US |
(41) | Date of publication of the application | 2013.05.31 |
(45) | Date of publication of patent granting decision: | 2015.08.31 |
(47) | Date of issuance of patent | 2016.03.31 |
(30) | Priority | 61/348,958, 2010.05.27, US |
(74) | Patent attorney | SOCOLOVA Sofia, Str. Drumul Viilor nr. 42, bloc 3, ap. 60, MD-2021, Chiєinгu, Republica Moldova |
| Substantive examiner(s) | JOVMIR Tudor |
(85) | Date of introducing the national procedure | 2012.12.20 |
(86) | International application | PCT/US2011/037083, 2011.05.19 |
(87) | International publication | WO 2011/149749 A1, 2011.12.01 |
| Payment for maintenance up to the date | 2025.05.19 |